Ultivue

Based upon technologies developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Ultivue’s scientific founders include Peng Yin, Ph.D. (Wyss Institute core faculty) and David Walt, Ph.D. (Illumina scientific founder and a Core Faculty Member at the Wyss Institute at Harvard University). Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs.